PulseAugur
实时 19:49:57
English(EN) Montana’s new “right to try” law can’t come soon enough for some

蒙大拿州的“尝试权”法为实验性药物获取带来希望

蒙大拿州已颁布一项新的“尝试权”法,旨在让绝症患者能够获取尚未获得FDA批准的实验性药物。一位名叫Kris DeVault的患者正寻求为其患有肌酸转运蛋白缺乏症的儿子Brody获取一种实验性药物。尽管该药物在动物和早期人体试验中显示出希望,但尚未获批,并且在美国面临更广泛获取的监管障碍,这让DeVault对其儿子的有限发育窗口感到担忧。 AI

排序理由 该集群讨论了一项影响实验性治疗获取的新州法律,这是一项重要的政策发展。[lever_c_demoted from significant: ic=1 ai=0.1]

在 MIT Technology Review 阅读 →

AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →

蒙大拿州的“尝试权”法为实验性药物获取带来希望

报道来源 [1]

  1. MIT Technology Review TIER_1 English(EN) · Jessica Hamzelou ·

    Montana’s new “right to try” law can’t come soon enough for some

    Kris DeVault is desperate. His son, Brody, was born in March 2023. It wasn’t long before he started to show signs of developmental delay, says DeVault. As time went on, Brody started missing key milestones in speech, movement, and coordination, he says. When Brody was around two …